baber/WOPTO huggingface dataset:
Patent AU-2019275587-B2 (AU)
Title: Systems and methods for ex-vivo organ care using lactate as an indicator
Inventor: HASSANEIN WALEED
IPC: A01N1/02
Filed: 2019-12-04
Granted: 2022-09-29
Abstract: The invention provides, in various embodiments, systems, devices and 
methods relating to ex-vivo organ care. In certain embodiments, the invention 
relates to maintaining an organ ex-vivo at near-physiologic conditions. The 
present application describes a method for using lactate measurement in the 
arterial and the venous blood lines of an organ care system heart perfusion 
device to evaluate 1) the overall perfusion status of an isolated heart, 2) the 
metabolic status of an isolated heart and 3) the overall vascular patency of an 
isolated donor heart. This aspect of the present invention uses the property of 
myocardial cell's unique ability to produce/generate lactate when they are 
starved of oxygen and to metabolize/utilize lactate for energy production when 
they are well perfused with oxygen.
Patent AU-2019413517-B2 (AU)
Title: Information receiving method, information sending method, terminal, and network side device
Inventor: SHEN XIAODONG
IPC: H04L5/00
Filed: 2019-12-26
Granted: 2022-12-22
Abstract: Provided are an information receiving method, an information sending method, a terminal, and a network side device. The information receiving method comprises: detecting an SSB; according to transmission configuration information of first information, determining a candidate SSB set quasi-co-located with a detected first SSB, wherein the first information comprises the SSB; and according to the first SSB and the candidate SSB set, carrying out first processing, wherein the first processing comprises one of the following: receiving system information scheduled by a physical control channel associated with the first SSB; carrying out radio link monitoring; and carrying out radio resource management and measurement.
Patent AU-2020203243-B2 (AU)
Title: Patient support surface control, end of life indication, and x-ray cassette sleeve
Inventor: NEWKIRK DAVID C
IPC: G03B42/02
Filed: 2020-05-19
Granted: 2022-05-19
Abstract: A patient support apparatus (10) may include a support surface (16) configured to conduct air 
along a top face of the support surface so that heat and moisture from a patient lying on the 
support surface are drawn away from the top face of the support surface. An opening may be 
formed in a side of the support surface. A cavity may extend from the opening into the support 
surface. An inlet port may be positioned within the cavity and fluidly coupled to the top face. A 
blower assembly may be configured to position within the cavity. The blower assembly may 
have an outlet port that couples to the inlet port when the blower assembly is positioned within 
the cavity. The blower assembly may conduct air through the inlet port to the top face of the 
support surface.  
FIG 1
0C 
(0 
-----0
Patent AU-2020210201-B2 (AU)
Title: Shielding device and method
Inventor: WAHNSCHAFFE DOUGLAS SCOTT
IPC: A61B6/10
Filed: 2020-07-29
Granted: 2021-09-30
Abstract: Some embodiments of a shielding device can include a base and a shield coupled to 
the base. The shielding device can be used to provide protection for a healthcare worker 
(e.g., physician, nurse, technician) during a medical procedure.  
1
Patent AU-2020210253-B2 (AU)
Title: Prosthetic valves with mechanically coupled leaflets
Inventor: DIENNO DUSTIN V
IPC: A61F2/24
Filed: 2020-07-30
Granted: 2022-01-27
Abstract: Described embodiments are directed toward centrally-opening leaflet prosthetic 
valve devices having a leaflet frame and a mechanically coupled leaflet. The described 
leaflet frames have projections that are configured to couple with apertures located 
within the leaflet attachment region of a leaflet. Some embodiments are further directed 
toward pulmonary valved conduits incorporating such leaflet and leaflet frame 
constructs. Methods of making and using such prosthetic valve devices are also 
described amongst others.  
74 
13410555 1 (GHMatters) P105875.AU.2
1/38 
C1-4 
0 - - - - - - -
00 
r%%J 
'-4 C4 
r4 co
Patent AU-2020232853-B2 (AU)
Title: Self-neutralizing amino acid based cationic compositions
Inventor: BURGO ROCCO V
IPC: C07C229/08
Filed: 2020-03-09
Granted: 2023-03-02
Abstract: The invention described herein includes a self-neutralizing amino acid-based cationic composition that contains an amino acid-based cationic ester, a nonionic amphiphile, and an anhydrous buffering agent. In an embodiment, the composition, when dispersed or dissolved in an aqueous solvent, provides a resultant solution/dispersion having a pH of greater than about 4. The amino acid-based cationic ester may be a reaction product of (i) an amino acid having a non-polar side chain, and an amine group that has been neutralized with an acid; with (ii) a long chain fatty alcohol. Also included within the scope of the invention are methods of preparing a self-neutralizing amino acid-based cationic composition, such method including combining an amino acid-based cationic ester, a nonionic amphiphile and an anhydrous buffering agent. The resulting composition is in an anhydrous solid form. Formulations containing the amino acid-based cationic ester and/or a composition that includes it, are also disclosed.
Patent AU-2020264460-B2 (AU)
Title: Crafting apparatus assemblies, systems, devices, kits, mechanisms and methodologies for utilizing the same
Inventor: CRYSTAL JEREMY BURTON
IPC: G05B19/12
Filed: 2020-04-30
Granted: 2023-08-10
Abstract: A tool including a tool surface and further including coding indicia linked, at least indirectly, with the surface of the tool, the coding indicia capable of being detected by a sensor, the coding indicia functioning as a pointer to information relating to said tool or its use.
Patent AU-2020267259-B2 (AU)
Title: Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
Inventor: ROSE JASON JOSEPH
IPC: A61K31/02
Filed: 2020-11-12
Granted: 2021-06-24
Abstract: In vitro and in vivo methods of removing carbon monoxide from hemoglobin in blood or 
animal tissue are described. Methods of treating carboxyhemoglobinemia (carbon monoxide 
poisoning) in a subject are also described. The methods include administering natural or artificial 
oxygen carriers that are in their reduced form. Methods of producing a reduced oxygen carrier are 
further described. Methods of treating cyanide poisoning or hydrogen sulfide poisoning with 
oxygen carriers are also described.
Patent AU-2020271556-B2 (AU)
Title: Curling mascara compositions
Inventor: LEE WILSON A
IPC: A61K8/34
Filed: 2020-04-12
Granted: 2023-02-02
Abstract: Mascara compositions that comprise ammonium styrene/acrylate copolymer and acrylates/VA copolymer as a plasticizer, in an aqueous base. In the concentrations specified, herein, the resulting mascara compositions have various useful properties that can be controlled, such as transition temperature, viscosity, dry time and degree of contraction. Compositions of the invention are hydrophilic. Nevertheless, after application, the compositions dry to a contracted hydrophobic state that retains curl. The applied composition resists transfer, smudging, flaking, humidity, oil and sebum, making them very suitable as 24 hour long wear cosmetics. Some preferred embodiments comprise an unusually high concentration of nylon fibers, which enhances volume and lengthening of eyelashes.
Patent AU-2021201242-B2 (AU)
Title: Quasi-recurrent neural network
Inventor: BRADBURY JAMES
IPC: G10L25/30
Filed: 2021-02-25
Granted: 2022-08-11
Abstract: The technology disclosed provides a quasi-recurrent neural network (QRNN) that 
alternates convolutional layers, which apply in parallel across timesteps, and minimalist 
recurrent pooling layers that apply in parallel across feature dimensions.
Patent AU-2021201770-B2 (AU)
Title: Compositions for improving cell viability and methods of use thereof
Inventor: COHEN JOSHUA B
IPC: A61P25/28
Filed: 2021-03-22
Granted: 2022-05-26
Abstract: C:\Interovn\NRPortbl\DCC\DAR\8395719_1.do x-31/01/2019 
ABSTRACT 
This invention relates to methods and compositions for use improving cell viability, 
particularly neural cell viability, and more particularly to methods and compositions for 
use improving cell viability by reducing reactive oxygen metabolite-mediated oxidative 
damage in a cell, regulating redox homeostasis in a cell, or reducing mitochondrial 
dysfunction in a cell. The invention further relates to the administration of the bile acid 
tauroursodeoxycholic acid (TUDCA) in combination with phenylbutyric Acid (PBA) to 
improve cell viability, and treat at least one symptom associated with, prevent the time of 
onset of, or slow the development of a disease related to oxidative stress.  
FIG.1 
120 
100 
% 80 
> 60 
°40 
20 
0T 
ci~ Nn3
Patent AU-2021203670-B2 (AU)
Title: Hybrid suture anchor
Inventor: ISSHIKI RYO
IPC: A61B17/00
Filed: 2021-06-04
Granted: 2023-02-23
Abstract: An anchor includes an expandable member configured to increase in size from a first 
pre-deployed condition to a second deployed condition; and a filament having a first filament 
end and a second filament end, and positioned in contacting relation to the expandable 
member in the second deployed condition. The anchor may also include a flat fibrous 
construct having a first end and a second end, and wherein the filament passes through the 
fibrous construct. The flat fibrous construct includes a first state in which the flat fibrous 
construct is uncompressed and extends along the longitudinal axis of the filament when in an 
unfolded and pre-deployed condition; and a second state in which the flat fibrous construct is 
compressed and expanded in a direction perpendicular to longitudinal axis of the filament in a 
deployed condition.  
13 8 
17757592_1 (GHMatters) P45874AU01
1/3 
100 
2 4B 
2B 
25,2582 4 
FIG. 1
Patent AU-2021264961-B2 (AU)
Title: Multi objective optimization of applications
Inventor: PARTHASARATHY SRINIVASAN
IPC: G06F11/34
Filed: 2021-04-29
Granted: 2023-11-09
Abstract: A system, computer program product, and method are provided for orchestrating a multi objective optimization of an application. A set of two or more key performance indicators (KPIs) and one or more parameters associated with the application are received. A machine learning (ML) based surrogate function learning model in combination with an acquisition function is leveraged to conduct one or more adaptive trials. Each trial consists of a specific configuration of the one or more parameters. A pareto surface of the KPIs of the application is computed based on the observations of KPI values from each adaptive trial. The pareto surface is explored and an optimal operating point is selected for the application. The application is then executed at the selected operating point.
Patent AU-2021383003-B2 (AU)
Title: Intelligent reliability evaluation and service life prediction method for kilometer deep well hoist brake
Inventor: LU HAO
IPC: G06F30/23
Filed: 2021-02-23
Granted: 2023-09-07
Abstract: An intelligent reliability evaluation and service life prediction method for a kilometer deep well hoist brake, the method including: the establishment of a digital twin model for a hoist brake, data acquisition and synchronization, and reliability evaluation and service life prediction, wherein the digital twin model for the hoist brake can accurately reflect actual physical characteristics of the hoist brake, the data acquisition and synchronization can realize real-time mapping between a physical entity of the hoist brake and the digital twin model therefor, and furthermore, on the basis of the digital twin model for the hoist brake, the reliability evaluation and service life prediction are realized. Digital twin technology is combined with a reliability analysis method, so that real-time updating of reliability evaluation and service life prediction of the hoist brake are realized, and the problem of it being difficult to execute reliability evaluation and service life prediction due to the fact that some of the parameters of the hoist brake are difficult to directly monitor, reliability data statistics are difficult to compile, or data samples are insufficient is solved.
Patent AU-2022200731-B2 (AU)
Title: Navigation systems and methods for reducing tracking interruptions during a surgical procedure
Inventor: MOCTEZUMA DE LA BARRERA JOSE LUIS
IPC: A61B34/20
Filed: 2022-02-04
Granted: 2023-11-30
Abstract: EDITORIAL NOTE 
APPLICATION NUMBER - 2022200731 
Please note: Abstract page 50 should be numbered 56.
ABSTRACT 
A method of operating a system comprising a manipulator configured to 
support a surgical tool, a navigation system comprising a localizer including a field-of
view and a tracker, and one or more controllers coupled to the manipulator and the 
navigation system, the method comprising the one or more controllers: detecting the 
tracker within the field-of-view of the localizer by establishing a line-of-sight 
relationship between the tracker and the localizer; generating a virtual line-of-sight 
boundary based on the line-of-sight relationship; associating a virtual object with one 
or more of the manipulator or the surgical tool; determining that a movement of one or 
more of the manipulator or the surgical tool causes a virtual collision between the 
virtual object and the virtual line-of-sight boundary; and enabling a response based on 
an outcome of determining that the movement causes the virtual collision.  
50
Patent AU-2022203728-B2 (AU)
Title: Applicators and cases for artificial lash extensions
Inventor: LOTTI SAHARA
IPC: A45D26/00
Filed: 2022-05-31
Granted: 2022-07-07
Abstract: APPLICATORS AND CASES FOR ARTIFICIAL LASH EXTENSIONS 
ABSTRACT 
Cases can be used to house sets of artificial lashes in a specified arrangement. For example, lash 
fusions may be placed within multiple predefined indentations in the shape of an eyelid.  
Applicators can be used to resiliently grasp all of the lash fusions in a set of lash extensions, and 
then simultaneously apply the entire set of lash extensions directly to the underside of the natural 
lashes. An applicator includes opposed arms that are connected to one another at an inner end 
designed to be gripped by an individual. The applicator can also include an outer end having a 
concave shape that is contoured to be substantially flush with the convex shape of the lash line 
and the predefined indentations of a case that includes the set of lash extensions.
Patent AU-2022381847-B2 (AU)
Title: Improvements in or relating to implantable ferromagnetic markers
Inventor: UDALE ROBINSON
IPC: A61B90/00
Filed: 2022-11-03
Granted: 2023-12-07
Abstract: An implantable susceptometry marker (1001) for use in surgical guidance comprising one or more ferromagnetic elements (1004a, 1004b, 1004c); and at least one diamagnetic element (1003); wherein the one or more ferromagnetic elements are formed of at least one ferromagnetic material having an initial relative permeability of at least about 10,000 and a saturation induction
Patent JP-4156169-B2 (JP)
IPC: A61B5/042
Filed: 2000-03-02
Granted: 2008-09-24
Abstract: A deflectable catheter comprises a catheter body (12), a tip section (14) and a control handle (16). The control handle, which is preferably curved, comprises a housing (102) having a generally hollow interior, a piston receiving assembly (116) at least partially within the interior of the housing, and a piston. The piston receiving assembly is afforded rotational movement but not longitudinal movement relative to the housing and comprises a generally tubular member defining a piston chamber. The piston is fixedly attached to the proximal end of the catheter body and extends into the piston chamber of the piston receiving assembly, wherein the piston is afforded longitudinal movement but not rotational movement relative to the piston receiving assembly. Rotation of the piston relative to the housing correspondingly rotates the piston receiving assembly, catheter body and tip section. A puller wire extends from the control handle, through a lumen in the catheter body and into a lumen in the tip section. The proximal end of the puller wire is anchored in the control handle, whereby distal movement of the piston relative to the piston receiving assembly results in distal movement of the catheter body relative to the puller wire. The puller wire is anchored in the tip section so that to distal movement of the catheter body relative to the puller wire deflects the tip section (14). <IMAGE>
Patent JP-3717391-B2 (JP)
IPC: F16B31/04
Filed: 2000-10-17
Granted: 2005-11-16
Abstract: A bolt for connecting two parts (8,9) together, comprising a bolt member (1) having a longitudinal axis, a screw-threaded first portion (2) provided with a screw thread, and a second portion (3) provided with a non-rotatable washer (5), e.g. a friction washer, non-rotatably connected to the polygonal circumference of the second portion (3) and having a first facial area (6) adapted to abut against a facial area (7) of one of the parts (8) and also having an opposite second facial area (11); a sleeve (19) screw-threadedly engaged with the screw-threaded first portion (2) and having a facial area (10) abutting against the second facial area (11) of the washer (5); first engaging means (13) on the sleeve (19) for enabling a given force to be applied to the sleeve in one direction; and second engaging means (12,14) on the bolt member (1,5) to enable a given force to be applied in an opposite direction to that applied to the sleeve, so that when a given force is applied in a first direction to the bolt member (1,5) through the second engaging means (12,14) and a given force is applied in an opposite direction to said sleeve (19) through the first engaging means, only the sleeve (19) turns while the bolt member (1,5) does not turn. <IMAGE>
Patent JP-4369044-B2 (JP)
IPC: A61P29/00
Filed: 1998-10-30
Granted: 2009-11-18
Abstract: There is disclosed a cancer malignancy diagnostic assay comprising obtaining a sample of a body fluid or tissue, performing a sequence identity assay to look for the presence of iPFK-2 specific sequences; an anticancer pharmaceutical composition comprising a specific antisense oligonucleotide to the inventive isolated iPFK-2 sequence and a pharmaceutically acceptable oligonucleotide carrier; and a method for finding therapeutically active anti-cancer compounds comprising screening compounds for activity to inhibit iPFK-2, preferably kinase activity.
Patent JP-4246918-B2 (JP)
IPC: H04W88/06
Filed: 1999-07-23
Granted: 2009-04-02
Abstract: In a multiple mode communication system (29), a radio communication device (22) selectively communicates, using a common pool of channels (42), through a cordless base station (30) and a cellular network having a plurality of cellular base stations (24). The radio communication device (22) determines and stores local station identifiers (88) for the cellular base stations (24) which are broadcasting message streams (48) over control channels (46) in a cordless radio coverage area (26) of the radio communication device (22). The radio communication device (22) transmits a message to the cordless base station (30) when a detected cellular base station identifier (51) matches one of the determined local station identifiers (88). The radio communication device (22) is prevented from transmitting a message when the detected cellular base station identifier (51) matches none of the local station identifiers (88).
Patent JP-4620251-B2 (JP)
IPC: A61K39/00
Filed: 1999-08-06
Granted: 2011-01-26
Abstract: Vaccine compositions of immunostimulatory oligonucleotides and saponin adjuvants and antigens and the use thereof for stimulating immunity, enhancing cell-mediated immunity, and enhancing antibody production are disclosed. Also described are immune adjuvant compositions comprising immunostimulatory oligonucleotides and saponin adjuvants, as well as methods for increasing an immune response using the same.
Patent JP-4145492-B2 (JP)
IPC: A61K31/435
Filed: 1999-09-17
Granted: 2008-09-03
Abstract: The compound (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo-[1,2-h] [1,7] naphthyridine inhibits the secretion of gastric acid.
Patent JP-3881519-B2 (JP)
IPC: F16D31/00
Filed: 1999-05-17
Granted: 2007-02-14
Abstract: A rotational control apparatus (10, 10a) for controlling the transmission of rotational forces between first and second relatively rotatable members (26, 120, 120a) includes a piston (76, 76a) interconnected for concurrent axial movement with the second member through a bearing unit (146) which enables relative rotation and concurrent axial shifting of the piston (76, 76a) and the second member (120, 120a). The piston (76, 76a) is only interconnected t o the first member (26) through the use of one or more springs (116) such that at least partial relative rotation between the piston (76, 76a) and the firs t member (26) is accomodated. The piston (76, 76a) includes one axial side surface (80) that defines an enlarged area to be acted upon by a source of pressurized fluid introduced into a chamber (92) to cause the piston (76, 76 a) and the second member (120, 120a) to simultaneously shift against the biasin g force of the springs (116) in order to control the selective engagement/disengagement between the first rotatable member (26) and the second member (120, 120a).
Patent JP-3382228-B2 (JP)
IPC: A23L33/00
Filed: 2001-03-15
Granted: 2003-03-04
Abstract: The present invention is directed to a DNA sequence coding for a polypeptide having phytase activity which DNA sequence is derived from specific groups of fungi, polypeptides encoded by such DNA sequences, vectors comprising such DNA sequences, bacteria or a fungal or yeast host transformed by such DNA sequences or vectors, a process for the preparation of a polypeptide by culturing such transformed hosts and composite feeds comprising one or more such polypeptides.
Patent JP-5377809-B2 (JP)
IPC: A61B6/06
Filed: 2001-06-15
Granted: 2013-12-25
Abstract: Collimation device (1) is shown of the type intended to direct an energy beam (13) in a given direction and at a given solid angle, the collimation device (1) being capable of being installed on output of an energy beam generating means and of being connected to a control unit (20). The collimation device (1) includes means for testing operation of the assembly formed by the energy beam generating means, the collimation device (1) and the control unit (20). <IMAGE>
Patent JP-4665367-B2 (JP)
IPC: H01L21/677
Filed: 2001-09-17
Granted: 2011-04-06
Abstract: PROBLEM TO BE SOLVED: To provide a method of handling a wafer that its prealignment is impossible in a simple operation without using an expensive conveyer while the throughput is not decreased. SOLUTION: Whether or not a wafer is successfully prealigned and the wafer eccentricity falls within an alignment range (tolerance) in a wafer inspection unit (wafer measurement unit) (3) are discriminated. When the eccentricity does not fall within the tolerance, the wafer is rotated in a prealignment unit so that the direction of the wafer eccentricity when the wafer is returned to a wafer carrier by using a wafer conveyer matches the direction in which the wafer carrier withdraws the wafer (5). Then, the wafer is returned to the wafer carrier by the wafer conveyer (6).
Patent JP-3936567-B2 (JP)
IPC: B60S5/04
Filed: 2001-10-29
Granted: 2007-06-27
Abstract: A rapid tyre inflation plant comprising a low pressure high flow inflating gas source (2), an inflation device (DG), a motor (T), a compressor (C) driven by said motor and a control circuit arranged to control feed of low pressure inflating gas from said inflating gas source (2) to said compressor (C) and the feed of inflating gas at a relatively high flow and pressure to said inflation device (DG). <IMAGE>